January 2, 2025
Newsroom
Displaying 51–60 of 143
November 21, 2024
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
November 8, 2024
Seer to Participate in Upcoming November Investor Conferences
November 6, 2024
Seer Reports Third Quarter 2024 Financial Results
November 6, 2024
Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
October 31, 2024
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
October 21, 2024
Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024
October 17, 2024
Seer to Report Third Quarter 2024 Financial Results on November 6, 2024
August 22, 2024
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 14, 2024
Seer Appoints Nicolas Roelofs to its Board of Directors
No results found.
Starting your proteomics research is effortless
Connect with an expert to discuss which path to the full proteome is right for you.
-
Bring the Proteograph Product Suite in-house
-
Run a project with
Seer Technology
Access Center -
Conduct a project with
a Seer service provider
or Center of Excellence